Literature DB >> 22925580

Structural basis of substrate specificity and selectivity of murine cytosolic 5'-nucleotidase III.

Christina L Grobosky1, Jennifer B Lopez, Sarahbeth Rennie, Dionysus J Skopelitis, Amanda T Wiest, Craig A Bingman, Eduard Bitto.   

Abstract

Cytosolic 5'-nucleotidase III (cN-III) is responsible for selective degradation of pyrimidine 5'-monoribonucleotides during maturation of reticulocytes to erythrocytes. The lack of this enzymatic activity due to genetic aberrations or lead poisoning results in a mild to moderate nonspherocytic hemolytic anemia. In affected individuals, pyrimidine nucleotides as well as their precursor polymers and their off-path metabolites accumulate in erythrocytes, interfering with their proper function in ways that are not yet fully understood. This report describes the first X-ray structure of a catalytically inactivated variant of murine cN-III with a natural substrate, uridine 5'-monophosphate, in the active site at 1.74Å resolution. The structure captures in an atomic detail the closed conformation that cN-III adopts upon substrate binding. Structure and sequence analysis coupled with enzymatic characterization of several mutants confirmed that the aromatic ring of a nitrogenous base of substrate nucleotide is stabilized by parallel π-stacking interactions with conserved aromatic rings of Trp113 and His68. The nitrogenous base is further stabilized by T-shaped stacking with the conserved aromatic ring of Tyr114, as well as by polar contacts with side chains of Thr66 and Ser117. Two water molecules help to stabilize the nucleotide binding by bridging it to protein residues Asp72 and His68 via hydrogen bonds. Finally, fully conserved Glu96 is responsible for recognition of ribose ring via two hydrogen bonds. The presented substrate complex structure elucidates how cN-III achieves specificity for pyrimidine 5'-nucleotides and how it selects against purine 5'-nucleotides.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925580     DOI: 10.1016/j.jmb.2012.08.014

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  3 in total

1.  Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.

Authors:  Dorota Kubacka; Mateusz Kozarski; Marek R Baranowski; Radoslaw Wojcik; Joanna Panecka-Hofman; Dominika Strzelecka; Jerome Basquin; Jacek Jemielity; Joanna Kowalska
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-29

2.  Identification of Drosophila and human 7-methyl GMP-specific nucleotidases.

Authors:  Juliane Buschmann; Bodo Moritz; Mandy Jeske; Hauke Lilie; Angelika Schierhorn; Elmar Wahle
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

3.  Crystal structures of the novel cytosolic 5'-nucleotidase IIIB explain its preference for m7GMP.

Authors:  Thomas Monecke; Juliane Buschmann; Piotr Neumann; Elmar Wahle; Ralf Ficner
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.